World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Barnes, Karen I ^a   Lindegardh, Niklas ^b,c   Ogundahunsi, Olumide ^d   Olliaro, Piero ^d   Plowe, Christopher V ^e   Randrianarivelojosia, Milijaona ^f   Gbotosho, Grace O ^g   Watkins, William M ^c   Sibley, Carol H ^h   White, Nicholas J ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^g UNIVERSITY OF IBADAN   (Nigeria)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BENFLUMETOL; FANSIDAR; MEFLOQUINE; PIPERAQUINE; QUININE;

DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; MALARIA; PHARMACODYNAMICS; QUALITY CONTROL; REVIEW; TREATMENT RESPONSE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL (TOPIC); DATA BASE; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; HEALTH; INFANT; INTERNET; MALE; NEWBORN; PREGNANCY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DATABASES AS TOPIC; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERNET; MALARIA; MALE; PREGNANCY; WORLD HEALTH;

EID: 35248843585     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-122     Document Type: Review

References (30)

1. The rationale and plan for creating a World Antimalarial Resistance Network. CH Sibley KI Barnes CV Plowe, Malar J 2007 6 1 118 10.1186/1475-2875-6- 118 17822531
2. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. R McGready K Stepniewska N Lindegardh EA Ashley Y La P Singhasivanon NJ White F Nosten, Eur J Clin Pharmacol 2006 62 1021 1031 10.1007/s00228-006-0199-7 17053895
3. Therapeutic monitoring of chloroquine in pregnant women with malaria. TO Fakeye FA Fehintola OG Ademowo O Walker, West Afr J Med 2002 21 286 287 12665265
4. Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria. K Na Bangchang TM Davis S Looareesuwan NJ White D Bunnag J Karbwang, Trans R Soc Trop Med Hyg 1994 88 321 323 10.1016/0035-9203(94)90101-5 7974678
5. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. R McGready K Stepniewska MD Edstein T Cho G Gilveray S Looareesuwan NJ White F Nosten, Eur J Clin Pharmacol 2003 59 545 552 10.1007/s00228-003-0652-9 12955371
6. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. R McGready K Stepniewska SA Ward T Cho G Gilveray S Looareesuwan NJ White F Nosten, Eur J Clin Pharmacol 2006 62 367 371 10.1007/s00228-006-0118-y 16552504
7. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: paediatric dosing implications. KI Barnes F Little PJ Smith A Evans WM Watkins NJ White, Clin Pharmacol Ther 2006 80 582 596 10.1016/j.clpt.2006.08.016 17178260
8. Chemoresistance of P. falciparum in urban areas of Yaounde, Cameroon. Part 1: Surveillance of in vitro and in vivo resistance Plasmodium falciparum to chloroquine from 1994 to 1999 in Yaounde, Cameroon. P Ringwald A Same Okobo A Keundjian D Kedy Mangamba LK Basco, Trop Med Int Health 2000 5 612 629 10.1046/j.1365-3156.2000.00613.x 11044275
9. The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. FW Hombhanje I Hwaihwanje T Tsukahara J Saruwatari M Nakagawa H Osawa MM Paniu N Takahashi JK Lum B Aumora A Masta M Sapuri T Kobayakawa A Kaneko T Ishizaki, Br J Clin Pharmacol 2005 59 298 301 10.1111/j.1365-2125.2004.02257.x 15752375
10. Comparison of the in-vitro activity of amodiaquine and its main metabolite, mono-desethyl amodiaquine in Plasmodium falciparum. U Gerstner S Prajakwong G Wiedermann J Sirichaisinthop G Wernsdorfer WH Wernsdorfer, Wien Klin Wochenschr 2003 115 Suppl 3 33 38 15508778
11. Does a stable isotopically labelled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. S Wang M Cyronak E Yang, J Pharm Biomed Anal 2007 43 701 707 10.1016/j.jpba.2006.08.010 16959461
12. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. MD Green H Nettey O Villalva Rojas C Pamanivong L Khounsaknalath M Grande Ortiz PN Newton FM Fernandez L Vongsack O Manolin, J Pharm Biomed Anal 2007 43 105 110 10.1016/j.jpba.2006.06.047 16930916
13. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. FO Ter Kuile C Luxemburger F Nosten KL Thwai T Chongsuphajaisiddhi NJ White, Trans R Soc Trop Med Hyg 1995 89 660 664 10.1016/0035-9203(95)90435-2 8594690
14. Alpha-1 acid glycoprotein inhibits the effects of quinine on the growth of Plasmodium falciparum in vitro. HD Birley RN Davidson JG Raynes PL Chidioni KP McAdam, Trans R Soc Trop Med Hyg 1992 86 377 10.1016/0035-9203(92)90227-4 1440809
15. The Effects of alpha-1-acid glycoprotein on the reversal of chloroquine resistance in Plasmodium falciparum. GO Gbotosho OA Ogundahunsi CT Happi DE Kyle L Gerena W Milhous A Sowunmi AM Oduola LA Salako, Ann Trop Med Parasitol 2006 100 571 578 10.1179/136485906X118486 16989682
16. Binding of artemether and lumefantrine to plasma proteins and erythrocytes. D Colussi C Parisot F Legay G Lefevre, Eur J Pharm Sci 1999 9 1 9 16 10.1016/S0928-0987(99)00037-8 10493991
17. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. F Smithuis MK Kyaw O Phe KZ Aye L Htet M Barends N Lindegardh T Singtoroj E Ashley S Lwin K Stepniewska NJ White, Lancet 2006 367 2075 2085 10.1016/S0140-6736(06)68931-9 16798391
18. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. EN Gitau SN Muchohi BR Ogutu IM Githiga GO Kokwaro, J Chromatogr B Analyt Technol Biomed Life Sci 2004 799 173 177 10.1016/j.jchromb.2003.10.006 14659450
19. Automated solid-phase extraction method for the determination of atovaquone in capillary blood applied onto sampling paper by rapid high-performance liquid chromatography. N Lindegardh L Funding Y Bergqvist, J Chromatogr B 2001 758 137 144 10.1016/S0378-4347(01)00160-8
20. Effect of chlorphemiramine on the pharmacokinetics of and response to chloroquine of Nigerian children with falciparum malaria. CA Okonkwo HA Coker PU Agomo JA Ogunbanwo AG Mafe CO Agomo BM Afolabi, Trans R Soc Trop Med Hyg 1999 93 306 311 10.1016/S0035-9203(99)90033-0 10492767
21. Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations. A Kaneko Y Berggvist G Taleo T Kobayakawa T Ishizaki A Bjorkman, Pharmacogenetics 1999 9 317 326 10.1097/00008571- 199910000-00005 10471063
22. Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: a new methodology. EK Mberu DK Muhia WM Watkins, J Chromatogr 1992 581 156 160 10.1016/0378-4347(92)80461-X 1430001
23. High performance liquid chromatographic determination of quinine in plasma, whole blood and samples dried on filter paper. U Hellgren T Villen O Ericsson, J Chromatogr 1990 528 221 227 10.1016/S0378-4347(00)82379-8 2384556
24. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. LM Slutsker CO Khoromana D Payne CR Allen JJ Wirima DL Heymann L Patchen RW Steketee, Bull World Health Organ 1990 68 53 59 2189586
25. Efficacy of artemether-luemfantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. MB Denis R Tsuyuoka P Lim N Lindegardh P Yi SN Top D Socheat T Fandeur A Annerberg EM Christophel P Ringwald, Trop Med Int Health 2006 11 1800 1807 10.1111/j.1365-3156.2006.01739.x 17176344
26. Clinical Pharmacokinetics and Pharmacodynamics of artemether- lumefantrine. NJ White M van Vugt F Ezzet, Clin Pharmacokinet 1999 37 105 125 10.2165/00003088-199937020-00002 10496300
27. Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. S Pukrittayakamee s Wanwimolruk K Stepniewska A Jantra S Huyakorn S Looareesuwan NJ White, Antimicrob Agents Chemother 2003 47 3458 3463 14576102 10.1128/AAC.47.11.3458-3463.2003
28. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Document No. WHO/HTM/RBM200350 Geneva World Health Organization Geneva, Switzerland: WHO/HTM/RBM 2003
29. World Antimalarial Resistance Network (WARN) I: Clinical efficacy of antimalarial therapy. RN Price G Dorsey EA Ashley KI Barnes JK Baird U d'Alessandro PJ Guerin MK Laufer I Naidoo F Nosten P Olliaro CV Plowe P Ringwald CH Sibley K Stepniewska NJ White, Malar J 2007 6 1 119 10.1186/1475-2875-6-119 17822532
30. World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria. CV Plowe C Roper JW Barnwell CT Happi HH Joshi W Mbacham SR Meshnick K Mugittu I Naidoo RN Price RW Shafer CH Sibley CJ Sutherland PA Zimmerman PJ Rosenthal, Malar J 2007 6 1 121 10.1186/1475-2875-6-121 17822535